Skip to Main Content

Paper Details

Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.
Oncologist
6
2020
Author NameAffiliation
Naoto KondoNagoya City University Hospital
  • 1 - 1

Datasets

Release 1.2